Isolated thyroid metastasis from renal cell carcinoma
INTRODUCTION
Renal cell carcinomas (RCC), (also known as renal adenocarcinoma) are most common cancer type of kidneys originating from proximal tubules. It accounts for 2-3% of all adult malignancies and is also the seventh most common cancer in men and the ninth most common cancer in women (1) . Renal cell carcinoma can metastasize to all organs hematogenously. In 30% of the cases, metastasis is present at diagnosis (2) . The most common sites of metastasis are lungs, bone, lymph nodes, and liver (3) . Gastric, brain, and skin involvement are also rarely seen. Although the thyroid gland is the second most common vascular organ of the body following the adrenal glands, metastasis of RCC is seen very rarely. In the autopsy series, tumors that metastasize to the thyroid are generally lung, breast, kidney, and head and neck (4) . Isolated thyroid metastasis of RCC is very rare. When present, metastatic RCC mimics primary tumors of the thyroid gland. Renal cell carcinoma generally presents as a mass in the neck.
We describe herein a patient with solitary metastasis to the thyroid, who had undergone a left nephrectomy for RCC 17 months previously.
CASE PRESENTATION
A 64-year-old woman with a history of 15 years of non-toxic multinodular goitre was consulted to our clinic from urology. She had no other symptoms such as dysphagia or dyspnea. A physical examination revealed palpable nodules on both sites of the thyroid gland. She had a left nephrectomy operation 17 months earlier. She was followed-up without any other treatment. On follow-up, thoracoabdominal computed tomography (CT) showed enlargement of the thyroid gland and hypoechoic nodule with a diameter of 22 mm in the left lobe of the thyroid gland ( Figure 1) . Ultrasound was performed on this neck. There was heterogeneity of the gland and there was a 22 mm hypoechoic nodule in the left lobe. The result of the radiological features and the thyroid volume led us to operate the patient. She did not accept the fine needle aspiration cytology.
A total thyroidectomy was performed in our clinic. Parathyroid glands and recurrent nerves were recognized and preserved. Macroscopic examination of the specimen showed that there is a 2 cm and 0.5 cm nodule and an ill-defined 0.8 cm nodule on the left lobe. The right lobe was normal. Microscopic examination revealed that there is lymphocytic thyroiditis and nodular hyperplasia in the nodule that is 2 cm in diameter, but there are some atypical cells with clear cytoplasm and large vesicular nuclei and prominent nucleoli in the nodules (0.5 cm diameter). The same atypical cells were also found in an area of 0.8 cm in diameter, in the same lobe out of the nodules described. We learned from the history of the patient that she had left nephrectomy 16 months ago for pT3 RCC. Immunohistochemical examination showed strong immunoreactivity with RCC and CD10 and vimentin. These neoplastic cells were negative for thyroid transcription factor-1 (TTF-1). These findings proved that these two nodules, which are 0.8 and 0.5 in diameter, are the metastasis of RCC (Figure 2) . After the operation, the patient was referred to the oncology clinic.
DISCUSSION
Tumors of thyroid glands are mostly primary tumors, which are papillary, follicular, medullary, and anaplastic carcinomas in the order of frequency. On the other hand, metastatic thyroid gland tumors are seen very rarely and account for 2-3% of the thyroid malignancies (5). Common primary tumors metastasizing to the thyroid are lung, breast, kidney, and head and neck (4). These secondary thyroid gland tumors are found in 5-24% of the autopsy series. Metastases to thyroid in these autopsy series are generally multifocal, but in clinical series, metastases are solitary and <15 mm in size (6). Our patient displays similarities with literature in terms of the tumor diameter.
According to the article published by Chung et al. (7), the most common non-thyroid malignancies metastasizing to the thyroid are RCC (48.1%), colorectal (10.4%), lung (8.3%), breast carcinoma (7.8%), and sarcoma (4.0%). Metastases are generally nodular (44.2%) and are more common in females as observed in our case.
Renal cell carcinoma is the most common and very aggressive tumor of the urinary system. Its incidence increases with age. Until the widespread use of screening tests in recent years, many of the detected RCC had been metastasized. However, nowadays, by the use of these screening tests, 70% of them are detected as an incidental finding (8) . This induces early detection of the cancer. However, despite early detection and surgical treatment, patients do not recover from the disease. We can see the metastasis of RCC even 10-20 years after diagnosis. Distant metastasis may be seen in one out of three patients. Our patient had left nephrectomy 16 months ago for pT3 RCC.
Renal cell carcinoma spreads hematogenously or through the lymphatic pathway to distant organs. The metastatic pathway is unpredictable for RCC. The lung, bone, liver, adrenal glands, brain, and skin are the most common sites of metastasis (8) . The less frequent distant metastatic sites are orbit, parotid gland, nasal and paranasal cavities, tongue and tonsils, heart, skin, ovaries, uterus, testis, and thyroid glands.
The clinical findings of the primary and metastatic cancers of the thyroid gland are similar. We may not be able to differentiate them even with radiological evidences. Sometimes, fine needle aspiration biopsy may not be helpful in differentiating primary tumor from metastasis. However, if the pathologist is aware of the oncologic history of the patient, then by the use different antibodies and immunohistochemical studies, he/ she may discriminate the pathology (9).
Thyroidectomy is recommended for isolated solitary thyroid metastasis of RCC. The mean survival rate after surgery is variable in the literature because the information about survival is limited to case reports. Heffess et al. (9) reported a series of 36 cases. According to this series, the mean overall survival period was 12.3 years from nephrectomy and 6.4 year from the date of thyroid metastasis. Machens and Dralle (10) reported that after definitive surgery of the thyroid metastasis of RCC, the mean survival rate may rise up to 30-60%. Considering that our patient, who was at an advanced age and presented with two nodules at a diameter of 5 mm and 8 mm, would have a poor prognosis, we are monitoring her closely in order to share her survival data in future studies.
CONCLUSION
Renal cell carcinoma can metastasize to distant organs even after many years. The thyroid gland is rarely affected by this. When the patient referred to our clinic with the thyroid nod- ule, we had data about the oncological history of the patient. If the patient had isolated thyroid metastases from RCC, thyroidectomy must be performed to improve prognosis. 
